摘要 |
The present invention provides in general an artificial cell, an isolated mutant ERalpha, an isolated polynucleotide encoding the mutant ERalpha, a method for quantitatively analyzing an activity for transactivation of a reporter gene by a test ERalpha, a method for screening a mutant ligand dependent transcriptional factor, a method for evaluating an activity for transactivation of a reporter gene by a test ERalpha, a method for screening a compound useful for treating a disorder of a mutant ERalpha, a pharmaceutical agent useful for treating an estrogenic disorder of a mutant ERalpha, use of the mutant ERalpha, a method for diagnosing a genotype of a polynucleotide encoding a test ERalpha, a method for diagnosing a genotype of a polynucleotide encoding a test ERalpha and a method for diagnosing a phenotype of a test ERalpha.
|